🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Systematic review: Significant gender inequities persist in leadership roles at US academic medical centers, despite efforts to promote gender equity. ja.ma/3RE8VqY @morganslevy

Congratulations Morgan S. Levy, MD, MPH (she/her)!! Academic medicine is at a critical junction- JAMA Network Open Melina Kibbe UVA School of Medicine

#Radonc representation on National Comprehensive Cancer Network (NCCN) Treatment Guideline Committees is <10%, even for committees that recommend #radiation. Additionally, certain institutions have nominated relatively few ☢️👩‍⚕️ for their designated slots. Glad to see this📰 finally published. advancesradonc.org/article/S2452-…

I no longer need to have friends at the USMLE (I hope somebody gets this reference). Step 3 done! ✅

Our SWRO merch store is live! From tumblers, tote bags to mugs, notepads, and pins, we’ve got the perfect way to celebrate your SWRO spirit every day. Shop now at tinyurl.com/SWROMerch!

Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized The latest IBCG consensus in European Urology offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate

🎖️Trainees in oncology and across all fields of medicine! Do not miss this manuscript on how to effectively respond to reviewer comments! Thanks Andrew Vickers Rod Dunn Christian Gratzke Morgan Roupret Alberto Briganti et al. European Urology Eur Urol Focus European Urology Oncology 🙏 OncoAlert

So excited to serve as the Society for Women in Radiation Oncology Communications Chair this year! Look forward to working with this incredible team to foster community and promote women and underrepresented minorities in radiation oncology!! SWRO ☢️👩🏻‍⚕️ #radonc

Congratulations Morgan S. Levy, MD, MPH (she/her) You are perfect for the role!!

New article on GRID therapy- Great work Dr. Knight! Reported Early Clinical Outcomes of Forward-Planned Multileaf Collimator-Based 3‐Dimensional Conformal Spatially Fractionated Radiation Therapy Technique for Large and Bulky Tumors - ScienceDirect sciencedirect.com/science/articl…

EMBRACE II: New standard of care for locally advanced cervical cancer! 📌 Advanced RT technology. 📌 Image-guided adaptive brachytherapy. 📌 Limited overall treatment time. 📌 Excellent disease control and overall survival. 📌 Low late severe morbidity. #ESTRO2025

PORTEC 4a results . High risk benefits from EBRT ( only 25% had LND) and low risk has small but non inferior difference in vaginal recurrence with VBT DrKamrava Andrew Keller

MCC trainees bringing their "A" game to Markey Research Day. Proud of the RPLP med students and Rad Onc residents bringing such a great effort forward.

It’s #nationalclinicaltrials day. All of the treatments and therapies today started as a clinical trial or clinical research study. This work is critical to the future of cancer care. Learn more about participating in a clinical trial at Markey Cancer Center here: ukhealthcare.uky.edu/markey-cancer-…

I can’t believe I already am starting the last month of intern year! I have learned so much this year, but am excited to finally start Radiation Oncology in July. ☢️🥰 #radonc

Use of local estrogen therapy among breast cancer patients #ASCO25 abstract Retrospective cohort study of 18,620 breast cancer pts 65+ showed local vaginal estrogen users (n=800) had ⭐️improved ⭐️overall survival!! OncoAlert ascopubs.org/doi/10.1200/JC…

A cancer #misinformation Tweetorial based on MS4 Brandon M. Godinich MBA, MHA's #ASCO25 ASCO research: "Cancer #misinformation and trust in doctors and scientists among cancer survivors." Let's talk about the concern many patients have about how to get quality health information... (1/🧵)

Phase 2 study of pembrolizumab added to chemoradiation therapy in #vulvarcancer w cisplatin yields 75% response rate and manageable AE #ASCO25 #gyncsm

This #WeWhoCurie Wednesday, we feature Dr. Allison Rau, our 2025-2026 Chair! ☢️ Dr. Rau is a PGY3 at the University of Calgary 🇨🇦. She is passionate about expanding the reach and presence of SWRO internationally. We can't wait to see what Dr. Rau will accomplish this year!

Excited to officially start Rad Onc Residency in a week from now! Have appreciated the warm welcome this year while I have been an intern in surgery. 🥰 UK RadOnc